Schizophrenia and Psychotic Disorders, PSYCH 302 Ch. 8 – Study Notes
offline

Source: Abnormal Psychology, University of Florida

Tags: schizophrenia, psychosis, delusions, hallucinations, positive symptoms, negative symptoms, dopamine hypothesis, antipsychotics, neuroleptics, schizoaffective, schizophreniform, catatonia, avolition, restricted affect

Difficulty: Intermediate-Advanced | Prerequisites: Basic neuroscience concepts (neurotransmitters, brain structures), understanding of genetic research methods (twin studies, concordance rates)


Big Picture

Schizophrenia is among the most severe and debilitating of all mental disorders. It is characterised by psychosis, the inability to distinguish real from unreal, and it affects virtually every domain of functioning: thinking, perception, emotion, motivation, and social behaviour. The disorder exists on a spectrum of severity, with related conditions (schizoaffective, schizophreniform, brief psychotic disorder, delusional disorder) falling along a continuum. Understanding schizophrenia requires integrating biological theories (genetics, brain structure, neurotransmitters) with psychosocial perspectives (stress, family dynamics, culture). Treatment has advanced substantially since the 1950s with antipsychotic medication, but full recovery remains uncommon and long-term management is usually necessary.


TL;DR

Schizophrenia involves psychotic symptoms (delusions, hallucinations, disorganised thought/behaviour) and negative symptoms (restricted affect, avolition). It is a neurodevelopmental disorder with strong genetic contributions, abnormal brain structure and neurotransmitter function (especially dopamine), and psychosocial triggers. Antipsychotic medications manage positive symptoms but are less effective for negative symptoms. Comprehensive treatment combines medication with behavioural, cognitive, social, and family interventions.


Key Terms

Psychosis

Inability to distinguish between what is real and what is not. Can take many forms including delusions, hallucinations, and disorganised thinking.

Positive Symptoms

Overt expressions of unusual perceptions, thoughts, and behaviours that are "added" to normal experience: delusions, hallucinations, disorganised thought and speech, disorganised or catatonic behaviour.

Negative Symptoms

Qualities that are "subtracted" from normal functioning: restricted affect, avolition, asociality. More persistent, harder to treat, and more strongly associated with poor outcomes than positive symptoms.

Delusions

Fixed beliefs that are not amenable to change in light of conflicting evidence. DSM-5 changed the definition from "erroneous beliefs" to acknowledge the difficulty of establishing full falsity of a belief.

Think of it as: beliefs the person holds with absolute conviction despite overwhelming evidence to the contrary.

Hallucinations

Unreal perceptual experiences. Can involve any sense, but auditory hallucinations (hearing voices) are the most common in schizophrenia.

Formal Thought Disorder

The disorganised thinking characteristic of schizophrenia, evident in speech.

Loose Associations (Derailment)

Slipping from one topic to an unrelated topic with no coherent transition.

Neologisms

Made-up words that have meaning only to the person using them.

Clangs

Word associations based on sound rather than meaning.

Word Salad

Speech so disorganised that it is completely incoherent.

Catatonia

Disorganised behaviour reflecting unresponsiveness to the environment. Ranges from negativism (refusing instructions) to rigid or bizarre posturing to complete mutism.

Catatonic Excitement

Purposeless, excessive motor activity for no apparent reason.

Restricted Affect

Severe reduction or absence of emotional expression: fewer facial expressions, reduced eye contact, flat voice, limited use of gestures.

Anhedonia

Loss of ability to experience pleasure. People with schizophrenia self-report anhedonia but laboratory tests show normal levels of positive affect, suggesting possible limitations of self-report or secondary depression.

Avolition

Inability to initiate or persist at common, goal-directed activities. May include physical slowing, apparent lack of motivation, poor hygiene, and social withdrawal.

Asociality

Lack of desire to interact with others. Should only be diagnosed when the individual has access to welcoming relationships but shows no interest.

Prodromal Symptoms

Symptoms appearing before the acute phase: social withdrawal, unusual beliefs short of delusions, strange perceptual experiences short of hallucinations, mildly disorganised speech.

Residual Symptoms

Symptoms persisting after the acute phase, similar to prodromal symptoms.

Dementia Praecox

Emil Kraepelin's original label for schizophrenia, reflecting his belief that the disorder was a progressive, irreversible deterioration of the brain.

Expressed Emotion

A family environment characterised by overinvolvement, overprotectiveness, self-sacrificing attitudes, and simultaneous criticism, hostility, and resentment toward the family member with schizophrenia. Associated with higher relapse rates.


Core Content

Types of Delusions

  • Persecutory: belief that one is being watched, tormented, or conspired against

  • Delusion of reference: belief that random events or others' comments are directed at oneself

  • Grandiose: belief that one is a special being or possesses special powers

  • Thought insertion: belief that one's thoughts are being controlled by outside forces

Types of Hallucinations

  • Auditory: hearing voices (most common)

  • Visual: seeing things, usually accompanied by auditory hallucinations

  • Tactile: perception that something is happening on the surface of the body

  • Somatic: perception that something is happening inside the body

Cognitive Deficits

  • Deficits in attention, memory, and processing speed

  • Greater difficulty focusing and maintaining attention

  • Deficits in working memory (holding and manipulating information)

  • Difficulty distinguishing relevant from irrelevant information

  • These deficits may contribute to the development of hallucinations and delusions as the person struggles to make sense of overwhelming input

  • Relatives may show milder versions of these deficits even without schizophrenia symptoms

  • Cognitive deficits often appear before acute symptoms and do not improve with treatment

  • Strongly contribute to overall disability

Diagnosis (DSM-5)

  • Must show two or more psychotic symptoms, at least one of which must be delusions, hallucinations, or disorganised speech

  • Symptoms must be consistently and acutely present for at least one month

  • Must show symptoms for at least six months with impaired functioning

  • Symptoms cannot be attributed to substance use, medical condition, or a mood disorder

  • Catatonia, when present, is specified in the diagnosis

  • During the six months before and after the active phase, the person may show mostly negative symptoms with milder positive symptoms

  • DSM-5 removed earlier subtypes (e.g. paranoid schizophrenia)

Prognosis, Gender, and Sociocultural Factors

  • Usually chronic, with symptoms and impairments lasting many years even with treatment

  • Shorter life expectancy; higher rates of infectious and circulatory diseases

  • Stabilisation typically occurs within 5 to 10 years after onset

  • Women tend to have better prognosis: less hospitalisation, milder inter-episode symptoms, better social adjustment, better educational and occupational histories

  • Women's later onset (late twenties to early thirties vs. late teens to early twenties for men) may partly explain the gender difference

  • Oestrogen may affect dopamine regulation and be protective for women

  • Males show greater brain abnormalities than females with schizophrenia

  • More benign course in developing countries, possibly due to broader family support networks, lower expressed emotion, and greater community reintegration

  • Social drift: symptoms interfere with education and employment, causing downward movement in social class

Other Psychotic Disorders

  • Schizoaffective disorder: mix of schizophrenia and a mood disorder. Psychotic and mood symptoms co-occur. Requires two weeks of hallucinations or delusions without mood symptoms.

  • Schizophreniform disorder: meets schizophrenia criteria A, D, and E but symptoms last only 1 to 6 months. Majority eventually diagnosed with schizophrenia or schizoaffective disorder.

  • Brief psychotic disorder: sudden onset, lasts 1 day to 1 month, then symptoms completely resolve. High relapse risk but excellent long-term outcome.

  • Delusional disorder: delusions lasting at least one month about realistic situations, with no other psychotic symptoms. Affects females more; onset typically around age 40 to 49.

  • Schizotypal personality disorder: lifelong pattern of oddities in self-concept, relationships, thinking, and behaviour. Milder cognitive deficits, dopamine dysregulation, and brain abnormalities compared to schizophrenia. Falls on the schizophrenia spectrum and is also classified as a personality disorder.


Biological Theories

Genetics

  • Family, twin, and adoption studies demonstrate a genetic component

  • Children of parents with schizophrenia and monozygotic twins have the highest risk

  • Concordance: MZ twins ~46%, DZ twins ~14%

  • Finnish study: 83% of variance in schizophrenia attributable to genetic factors

  • Adoption studies (Tienari, Kety) confirm genetic transmission

  • No single gene accounts for schizophrenia; many gene differences are implicated

Brain Structure and Function

  • Viewed as a neurodevelopmental disorder

  • Gross reduction in grey matter in cortex (medial temporal, superior temporal, prefrontal areas)

  • Abnormal prefrontal cortex activity (involved in language, emotional expression, planning)

  • Hippocampus abnormalities in volume and shape; similar abnormalities in first-degree relatives

  • Reduced and abnormal white matter, especially in areas related to working memory; present before overt symptoms

  • Enlarged ventricles suggesting brain tissue atrophy

  • Adolescent brain development abnormalities may trigger the disorder

Damage to Developing Brain

  • Serious prenatal and birth complications are frequent

  • Perinatal hypoxia interacts with genetic vulnerability

  • Prenatal viral exposure, especially during the second trimester, disrupts brain development; people with schizophrenia are more likely to be born in spring (mothers exposed to flu in autumn/winter)

  • Maternal immune activation may damage fetal brain cells and dopamine systems

Neurotransmitters

  • Original dopamine hypothesis: excess dopamine in the brain causes schizophrenia symptoms. Supported by the fact that drugs blocking dopamine (phenothiazines) reduce positive symptoms, and drugs increasing dopamine (amphetamines) worsen them.

  • Revised dopamine hypothesis: excessive dopamine in the mesolimbic pathway (processing salience and reward) produces positive symptoms and motivational deficits. Low dopamine in the prefrontal cortex produces negative symptoms. This explains why traditional antipsychotics reduce positive but not negative symptoms.

  • Serotonin neurons regulate dopamine in the mesolimbic system; newer drugs bind to serotonin receptors

  • Abnormal GABA levels implicated

  • Glutamate pathways link cortex, limbic system, and thalamus; drugs blocking glutamate receptors (PCP, ketamine) produce hallucinations and delusions

Psychosocial Perspectives

  • Stressful circumstances can trigger new episodes; negative life events may themselves be prodromal symptoms

  • Immigration is associated with increased risk

  • Early theories blamed "schizophrenogenic mothers" (overprotective, rejecting, dominating) and double-bind communication, but these did not hold up to research

  • Expressed emotion in families (overinvolvement + hostility + criticism) is associated with higher relapse rates; interventions that reduce expressed emotion reduce relapse

  • Family members high in expressed emotion often have psychological disorders themselves; genetic factors shared with the patient may partly explain the association

Cognitive Perspectives (Beck and Rector)

  • People with schizophrenia conserve limited cognitive resources by using biased thinking styles

  • Delusions arise as explanations for strange perceptual experiences

  • Hallucinations result from hypersensitivity to perceptual input combined with external attribution

  • Negative symptoms arise from expectations that social interactions will be aversive

  • Cognitive therapies help patients identify and challenge delusional beliefs and hallucinatory experiences


Treatment

Typical Antipsychotics (Neuroleptics)

  • Chlorpromazine (first effective drug, 1950s) and others (trifluoperazine, thioridazine, fluphenazine, perphenazine)

  • Block dopamine receptors, reducing positive symptoms

  • Side effects: grogginess, dry mouth, blurred vision, weight changes, sexual dysfunction, depression

  • Akinesia (slowed motor activity, monotone speech, expressionless face)

  • Parkinsonian side effects: muscle stiffness, tremors, spasms, akathisia (inability to sit still)

  • Tardive dyskinesia: involuntary movements of tongue, face, mouth, or jaw. Irreversible. Occurs in 20% with long-term use.

  • More effective for positive than negative symptoms

  • Patients must continue medication to prevent relapse

Atypical Antipsychotics

  • More effective with fewer neurological side effects

  • Clozapine: binds to D4 receptor, influences serotonin. Helps patients who did not respond to neuroleptics. Reduces both positive and negative symptoms. Does not cause tardive dyskinesia. Risk of agranulocytosis (potentially fatal bone marrow deficiency), so used only after other atypical antipsychotics fail.

  • Others: risperidone (Risperdal), olanzapine (Zyprexa), ziprasidone (Geodon). No agranulocytosis risk, but significant side effects including weight gain, diabetes risk, sedation, sexual dysfunction.

  • Six-month remission rates: olanzapine highest, then quetiapine, perphenazine, ziprasidone, risperidone.

Psychological and Social Treatments

  • Cognitive treatments: help patients recognise and change demoralising attitudes, dispute delusional beliefs, develop realistic expectations about social interaction

  • Behavioural therapies: operant conditioning and modelling to teach conversational skills, self-care, and daily routines. Family members taught to ignore psychotic behaviour and reinforce appropriate behaviour.

  • Social interventions: self-help groups, social skills training, role-playing, problem-solving

  • Family therapy: education about schizophrenia, communication and problem-solving training, behavioural techniques for encouraging positive behaviour. Combined with medication, reduces relapse and improves adherence.

  • Assertive community treatment (ACT): comprehensive 24-hour services from multidisciplinary teams. Gold standard for community-based treatment. Includes the "lodge" model (residential treatment) and vocational rehabilitation. Reduces hospitalisation and is cost-effective, but chronically underfunded.


Common Misconceptions

  • "Schizophrenia means split personality." Schizophrenia involves a split in mental functions (thought, emotion, perception), not multiple personalities. DID is the disorder involving distinct identities.

  • "Positive symptoms are 'good' symptoms." "Positive" refers to the presence of abnormal experiences (delusions, hallucinations), not to anything beneficial.

  • "If medication controls the symptoms, the person is cured." Medication manages symptoms, particularly positive ones, but negative symptoms and cognitive deficits often persist. Lifelong treatment is typically needed.

  • "Schizophrenia is caused by bad parenting." The "schizophrenogenic mother" theory has been thoroughly discredited. Schizophrenia has strong biological and genetic roots, though family environment can influence relapse.


Why It Matters / Exam Flags

⚠️ Know the five domains: positive symptoms, negative symptoms, and cognitive deficits. Be able to list examples of each.

⚠️ The original vs. revised dopamine hypothesis is high-yield exam material.

⚠️ Tardive dyskinesia: what it is, its cause, and its irreversibility.

⚠️ Know the differences between typical and atypical antipsychotics, including clozapine's unique risk (agranulocytosis).

⚠️ Be able to distinguish schizophrenia from schizoaffective, schizophreniform, brief psychotic disorder, and delusional disorder.

⚠️ Expressed emotion: definition and its relationship to relapse.

⚠️ Prodromal and residual symptoms: know what they look like and when they occur relative to the acute phase.


Quick Self-Test

  1. True or False: Negative symptoms of schizophrenia are more responsive to medication than positive symptoms.

  1. Fill in the blank: __________ is a neurological side effect of long-term phenothiazine use involving involuntary facial and mouth movements.

  1. True or False: The concordance rate for schizophrenia in monozygotic twins is approximately 46%.

  1. Fill in the blank: Kraepelin originally labelled schizophrenia __________, believing it was a progressive and irreversible brain deterioration.

  1. True or False: Brief psychotic disorder can last up to six months.


Practice Q&A

Q: What is the revised dopamine hypothesis of schizophrenia?

A: Excessive dopamine activity in the mesolimbic pathway produces positive symptoms (hallucinations, delusions, motivational deficits), while low dopamine activity in the prefrontal cortex produces negative symptoms. This explains why traditional antipsychotics (which broadly reduce dopamine) help positive but not negative symptoms.

Q: How does schizoaffective disorder differ from schizophrenia?

A: Schizoaffective disorder involves a combination of psychotic symptoms and prominent mood symptoms (meeting criteria for major depressive or manic episode). It requires at least two weeks of hallucinations or delusions without mood symptoms to distinguish it from a mood disorder with psychotic features.

Q: What is expressed emotion, and how does it relate to schizophrenia outcomes?

A: Expressed emotion describes a family environment characterised by overinvolvement, overprotectiveness, self-sacrificing attitudes, and simultaneous criticism, hostility, and resentment. High expressed emotion is associated with higher relapse rates. Interventions that reduce expressed emotion in families have been shown to reduce relapse.

Q: Why is clozapine not used as a first-line treatment?

A: Clozapine carries a risk of agranulocytosis (a potentially fatal deficiency of infection-fighting granulocytes produced by bone marrow). It is reserved for patients who have not responded to other atypical antipsychotics, and patients must be closely monitored.

Q: What evidence supports the neurodevelopmental model of schizophrenia?

A: Prenatal and birth complications, perinatal hypoxia, prenatal viral exposure (especially during the second trimester), grey matter reductions, white matter abnormalities, hippocampal abnormalities, and enlarged ventricles all point to disrupted brain development. Many of these abnormalities are present before symptom onset.


Connections to Other Topics

Schizophrenia connects to the neuroscience of dopamine (relevant to ADHD and substance use disorders as well), mood disorders (through schizoaffective disorder), and personality disorders (schizotypal personality disorder falls on the schizophrenia spectrum). The concept of expressed emotion links to family systems theory. The dopamine hypothesis connects to the pharmacology of stimulant drugs and Parkinson's disease.


Related Terms / Search Tags

schizophrenia, psychosis, positive symptoms, negative symptoms, delusions, hallucinations, loose associations, word salad, neologisms, clangs, catatonia, restricted affect, avolition, anhedonia, asociality, prodromal, residual, dopamine hypothesis, mesolimbic pathway, prefrontal cortex, neuroleptics, phenothiazines, chlorpromazine, tardive dyskinesia, atypical antipsychotics, clozapine, agranulocytosis, risperidone, olanzapine, expressed emotion, schizoaffective, schizophreniform, brief psychotic disorder, delusional disorder, schizotypal, dementia praecox, Kraepelin, Bleuler, neurodevelopmental, PSYCH 302, abnormal psychology, exam 2